| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.37 | 0.03 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.31 | 0.08 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.3 | 0.05 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.29 | 0.03 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.29 | 0.05 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.29 | 0.4 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.27 | 0.08 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |